Prevalence and associated factors of metabolic syndrome in patients with rheumatoid arthritis at Cho Ray Hospital
Main Article Content
Abstract
Metabolic syndrome (MetS) is a prevalent comorbidity in patients with rheumatoid arthritis (RA), arising from chronic inflammation, oxidative stress, and the impact of therapeutic interventions. Beyond systemic metabolic disturbances, MetS is associated with numerous adverse outcomes, directly escalating the disease burden and cardiovascular risk. This cross-sectional study of 151 RA patients (age ≥ 18) at Cho Ray Hospital revealed a MetS prevalence of 39.1%, which remained high regardless of disease activity levels. Consequently, metabolic screening is strongly indicated for high-risk subgroups, particularly elderly females (age ≥ 60), overweight or obese individuals (BMI ≥ 25 kg/m²), and people with low LDL-c levels.
Article Details
Keywords
Rheumatoid arthritis, Metabolic syndrome, cardiovascular risk
References
2. Conforti A, Di Cola I, Pavlych V, et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev. 2021;20(2):102735. doi:10.1016/j.autrev.2020.102735.
3. Ferraz-Amaro I, Gonzalez-Juanatey C, Lopez-Mejias R, et al. Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm. 2013;2013:710928. doi:10.1155/2013/710928.
4. Hallajzadeh J, Safiri S, Mansournia MA, et al. Metabolic syndrome and its components among rheumatoid arthritis patients: a comprehensive updated systematic review and meta-analysis. PLoS One. 2017;12(3):e0170361. doi:10.1371/journal.pone.0170361.
5. Hee JY, Protani MM, Koh ET, et al. Metabolic syndrome and its effect on the outcomes of rheumatoid arthritis in a multi-ethnic cohort in Singapore. Clin Rheumatol. 2022;41(3):649-660. doi:10.1007/s10067-021-05945-8.
6. Bhattacharya PK, Barman B, Jamil M, et al. Metabolic syndrome and atherogenic indices in rheumatoid arthritis and their relationship with disease activity: a hospital-based study from Northeast India. J Transl Int Med. 2020;8(2):99-105. doi:10.2478/jtim-2020-0015.
7. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645. doi:10.1161/CIRCULATIONAHA.109.192644.
8. Dao HH, Do QT, Sakamoto J. Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther. 2010;12(6):R218. doi:10.1186/ar3203.
9. Dubovyk V, Vasileiadis GK, Fatima T, et al. Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study. RMD Open. 2024;10(2):e004227. doi:10.1136/rmdopen-2024-004227.
10. Xu H, Choi SE, Kang JK, et al. Basal metabolic rate and Charlson Comorbidity Index are independent predictors of metabolic syndrome in patients with rheumatoid arthritis. Joint Bone Spine. 2020;87(5):455-460. doi:10.1016/j.jbspin.2020.03.015.
11. Kerekes G, Nurmohamed MT, Gonzalez-Gay MA, et al. Rheumatoid arthritis and metabolic syndrome. Nat Rev Rheumatol. 2014;10(11):691-696. doi:10.1038/nrrheum.2014.121.
12. Blaton V. How is the metabolic syndrome related to the dyslipidemia? EJIFCC. 2007;18(1):15-22.